The effectiveness of antiplasmodial drugs against the blood stage of infection is increasingly threatened by the emergence and spread of drug-resistant parasites. Here a small library of “half-sandwich” cyclopentadienylruthenium(II) compounds of the general formula [(η5-C5R5)Ru(PPh3)(N-N)][PF6] was screened for activity against the blood stage of CQ-sensitive 3D7-GFP, CQ-resistant Dd2, and artemisinin-resistant IPC5202 Plasmodium falciparum strains and the liver stage of Plasmodium berghei. We showed that some of the compounds are potent dual-stage antiplasmodials, displaying Plasmodium falciparum-selective accumulation in infected erythrocytes. The study was coordinated by researchers from Faculdade de Farmácia with collaboration of researchers from IHMT, IMM and iBB-IST (Sandra Pinto). The results were published in Inorg. Chem.